Medtronic plc (NYSE:MDT) is one of the top low volatility healthcare stocks to buy now. On July 16, Mizuho raised the firm’s ...

In the latest trading session, Medtronic (MDT) closed at $91.97, marking a -1.04% move from the previous day. The stock fell short of the S&P 500, which registered a gain of 0.02% for the day. At the ...

One key theme that runs through the two examples here is consistency. On that score, Johnson & Johnson has the best track ...

ISRG is set to report second-quarter 2025 earnings on April 22. The Zacks Consensus Estimate for sales and earnings is pegged ...

CMS proposed Medicare coverage for Medtronic's renal denervation therapy for high blood pressure, signaling a key step toward broader adoption.

For the second quarter, Texas Instruments reported revenue of $4.45 billion, up 16% year-over-year and above the analyst ...

The stock is yielding a historically attractive 3.2% ... Right now one of the best healthcare stocks to look at is medical ...

Medtronic MDT underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below provides a concise overview of recent ratings by ...

We came across a bullish thesis on Medtronic plc on Max Dividends’s Substack. In this article, we will summarize the bulls’ ...

CFRA has a “buy” rating and $99 price target for MDT stock, which closed at $89.22 on July 15. More from U.S. News Recession 2025: What to Watch and How to Prepare ...

Key Points Medtronic faces several challenges, including slow revenue growth and uncertainty related to tariffs.However, the company has significant strengths, including a massive opportunity for its ...

Medtronic PLC stock grades by Barron's. View MDT fundamental and sentiment analysis powered by MarketGrader.